An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World Settings
Clinical trial NCT06013475 · COMPLETED
Trial details
- NCT number
- NCT06013475
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-31
- Primary completion
- 2024-06-28
- Enrollment
- 1375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.